Introduction
Membrane fusion is fundamental for membrane trafficking which supports the compartmentalization and secretion of various cellular components. Regardless of cell type or function, the basic mechanism used to overcome the energy barrier required to merge twol ipid bilayers appears to be highly conserved. In specialized secretory cells, such as neuronal and endocrine cells, membrane fusion, and subsequent release of biologically active molecules, is highly regulated by intracellular Ca 2+ levels. Ca 2+ -triggered membrane fusion has become the hallmark of exocytosis in these cells. While there has been some progress in understanding howt he lipid components can contribute to this process, the exact roles of known exocytotic proteins in vesicle trafficking and membrane merger is still controversial. Although the relationship between Ca 2+ concentration and release has been studied extensively over past decades, the molecular machinery by which Ca 2+ triggers and modulates native membrane fusion remains poorly understood.
The uncertainty surrounding the precise mechanism underlying Ca 2+ -triggered membrane fusion can be attributed, at least in part, to the intricate, interconnected steps of the exocytotic pathway.C a 2+ -triggered membrane fusion is preceded by several distinct mechanistic stages that transport, localize, and prepare the vesicle for efficient, triggered fusion. First, secretory vesicles must be formed and filled (biogenesis), and then theya re targeted to, attached, and immobilized at appropriate release sites on the plasma membrane (tethering/docking). Once vesicles are docked at release sites, theyu ndergo one or more ATPdependent reactions (priming) to become fusion competent; which priming events might occur before docking, and which after,i ss till somewhat unclear.T hese readyreleasable vesicles sit at the plasma membrane awaiting a rise in intracellular [Ca 2+ ]w hich triggers the merger of the vesicle and plasma membranes resulting in coordinated release of the vesicular contents. After fusion, vesicles are retrieved( endocytosis) and re-filled for subsequent rounds through this dynamic, cyclic pathway.T his makes the investigation of anyspecific stage of exocytosis in an intact cell problematic: a blockade at anys tage of the pathway will block secretion. A second problem in dissecting such unknown molecular mechanisms is that the proteins involved can be highly specialized, tightly regulated and are often of lower abundance. Effectively,these critical proteins are belowt he detection limits of manys tandard molecular assays, making them difficult to isolate or study in the native context (e.g. without substantial overexpression).
Model system and methods
The conserved nature of Ca 2+ -triggered membrane fusion 1, 2 allows for the use of simplified, in vitro model systems to study the underlying molecular mechanisms. Isolated secretory vesicles (cortical vesicles; CV) from sea urchin oocytes undergo fusion with the plasma membrane, [3] [4] [5] [6] [7] [8] other CV [9] [10] [11] [12] [13] [14] [15] [16] and artificial bilayers 17, 18 in response to an increase in [Ca 2+ ] free .U nlikeo ther types of secretory vesicles that tend to rapidly deprime during isolation, CV remain fully primed and fusion-ready,n ot requiring ATP or anyo ther cytosolic factors for fusion to occur. 3, 7 Furthermore, this in vitro fusion assay is not followed by anye ndocytotic event. This fast, native system thus enables the quantitative assessment of Ca 2+ -triggered membrane fusion without interference from other stages of the exocytotic pathway.T he resulting Ca 2+ -activity curves (fusion vs [Ca 2+ ] free )p rovide a measure of the fundamental ability of CV to fuse (extent) and howe fficient Ca 2+ is at initiating/regulating the fusion process (EC 50 ). A kinetic assay (fusion vs time) also provides information about fusion efficiency. Alterations in either fusion competencyor efficiencyc an then be tightly correlated to quantitative measures of the molecular make-up of the vesicles to definitively identify the underlying machinery. [9] [10] [11] [12] Large quantities of CV can be collected from a single urchin providing ample material for lipidomic and proteomic analyses. Additionally,r emoving the cytosol, plasma membrane, and all other cellular organelles reduces the complexity of the analysis by eliminating the majority of background components not involved in the fusion process itself. This substantially increases our ability to detect lower abundance proteins of interest. Thus, this system is highly amenable to the sensitive,coupled functional and molecular analyses that are necessary to identify key components of the native,Ca 2+ -triggered membrane fusion mechanism.
Isolation and treatment of cortical vesicles
Isolated CV-plasma membrane fragments (cell surface complex; CSC) or CV from unfertilized sea urchin oocytes are well established models for studying Ca 2+ triggered membrane fusion and have been described in detail. 8, 15, [19] [20] [21] Briefly,d ejellied eggs were homogenized followed by several wash steps to remove cytosol and other organelles, yielding isolated CSC. Then, CV were released from the plasma membrane fragments using chaotropic buffers (NH 4 Cl-and KCl-based) and isolated by centrifugation. Isolated CV were suspended in baseline intracellular medium (BIM; 210 mM potassium glutamate, 500 mM glycine, 10 mM NaCl, 10 mM Pipes, 0.05 mM CaCl 2 ,1mMMgCl 2 ,1mMEGTA; pH 6.7)
22 supplemented with 2.5 mM ATP and protease inhibitors. Stock solutions of the thiol-reactive reagents were either mixed with CV suspensions or CV were suspended directly into BIM containing the concentrations of thiol reagents indicated; for those cases in which dimethyl sulfoxide or dimethylformamide were required to solubilize reagents (i.e. lucifer yellowi odoacetamide, iodoacetamidofluorescein, phenylarsine oxide, diamide), parallel solvent controls (final concentration ≤ 1%) showed no effect on fusion. Free-floating CV were incubated with the reagents at 25°C for the indicated times, excess reagent wast hen removeda fter centrifugation, and the CV suspended in fresh BIM for fusion assays.
Functional fusion assays
Standard end point and kinetic assays were carried out using a straightforward light-scattering paradigm to quantify fusion. 9, 11, 13, 15, 20 Free-floating CV were plated in multi-well plates and lows peed centrifugation was used to bring the vesicles into contact at the bottom of the wells. Optical density measurements were taken before and after the addition of Ca 15 The data were normalized to the control conditions with the lowa nd high [Ca 2+ ] free plateaus defining 0% and 100% fusion, respectively.E nd point activity curves were fit with a lognormal cumulative function 4 to determine the extent, slope and Ca 2+ -sensitivity of fusion. For kinetic assays, the initial rate of fusion was determined from the ∆ optical density occurring overthe duration of the Ca 2+ -injection (450 ms).
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Analysis of vesicle membrane proteome CV were subjected to hypotonic lysis and membranes were isolated by ultracentrifugation (100,000 -200,000 × g). 10, 23 Fort he isolation of cholesterol-enriched membrane regions, the CV membranes were then fractioned on sucrose gradients (40%/30%/22%/10%, 25 mM Tris, pH 7) by density centrifugation. 24 The cholesterol rich membrane fragments were collected from the 22%/10% sucrose interface and then washed in Tris buffer.T he resulting membrane pellets were solubilized in 2DE buffer (8 M urea, 2 M thiourea, 4% CHAPS, protease inhibitors) and membrane proteins were resolved by optimized twodimensional electrophoresis protocols, as previously described. 25 In brief, the protein sample was normalized to 2m g/ml and mixed 1:1 with 2DE buffer containing ampholytes. The sample was then subjected to reduction (5 mM TCEP) and alkylation (2.5% acrylamide) steps before 100 µgwas passively loaded onto immobilized pH gradient strips (pH 3-10), and isoelectric focusing (IEF) was carried out at 4000 V for 37500 V h. After this 1 st dimension separation, the pH gradient strips were equilibrated in an SDS buffer (4 M urea, 2% SDS, 20% glycerol, 375 mM Tris pH 8.9) with additional reduction and alkylation steps, and then separated by SDS-PAGE( 5% T stacking gel; 10-14% T resolving gel). Toimprove the detection of thiollabeled proteins, the resolved membrane proteome was electro-transferred to 0.2 µmp olyvinylidenefluoride (PVDF) membrane using modified Towbin buffer (25 mMTris, 192 mM glycine, 20%methanol, and 0.025% SDS). The PVDF membranes were image for Lucifer yellow( 450/530), while a second set of corresponding gels were stained and imaged for total protein (SyproRuby; 480/620).
Interaction between proteins and lipids in membrane fusion
Fast, Ca 2+ -triggered membrane fusion requires the joint effort of proteins and lipids at or near the fusion site. The body of evidence indicates that membrane merger most likely occurs through a purely lipidic fusion pore. However, proteins are critical at several steps of the process that are likely to include bringing membranes into close apposition (e.g. bending or 'dimpling' membranes), overcoming the hydration barrier,t riggering the fusion mechanism, and expansion of the fusion pore. 26 The triggering event involves sensing an increase in intracellular [Ca 2+ ]( or another signal) and translating that into deformations or localized ruptures in the membranes. It is thought that Ca 2+ binding to a 'Ca 2+ -sensor' induces a conformational change resulting in the interaction of the protein(s) with the membrane surface and/or the insertion of a portion of a protein into the membrane which thereby alters both membrane stability and curvature. 27, 28 Once triggered, membrane fusion is thought to rapidly proceed through a series of transient high curvature lipidic intermediates: [29] [30] [31] the merger of the proximal leaflets leads to the formation of the stalk (net negative curvature -concave)followed by the merger of the distal leaflets resulting in the opening of a fusion pore (net positive curvature -convex). Thus, the energy required to rearrange, bend, and merge membranes, and in turn the ability to fuse, depends to a large extent on the specific lipid components present. There is at least one critical protein required to trigger fusion as treatment with certain reagents (e.g. specific thiol-reactive compounds) leave vesicles fusion incompetent, but there are also likely several accessory proteins that define the physiological efficiencyofthe membrane merger process. 11, 53 The role of lipids in membrane fusion has been studied in various artificial bilayer and biological model systems. Introduction of lipids with spontaneous negative curvature (small polar head group and bulkyh ydrophobic tail -forms concave structures; e.g. arachidonic acid) into the apposed monolayers has been shown to promote fusion, [32] [33] [34] whereas the introduction of lipids with spontaneous positive curvature (large polar head group and slim hydrophobic tail -forms convex structures; e.g. lysophosphatidylcholine) inhibited fusion. 15, [33] [34] [35] [36] This is consistent with either promoting or inhibiting the formation of the stalk intermediate: negative curvature lipids facilitate the transition through the stalk by lowering the energy required to bend the membranes into this high negative curvature structure. Recently work on fast, Ca 2+ -triggered membrane fusion has focused on cholesterol, an abundant sterol enriched in secretory vesicles, 9, 37, 38 which can serve as a local source of negative curvature. 39 In isolated CV, altering endogenous membrane cholesterol by chelation with methyl-β-cyclodextran (mβcd), enzymatic depletion with cholesterol oxidase, or sequestration with polyene antibiotics (e.g. filipin) potently inhibited fusion. 9 After cholesterol chelation or sequestration, the delivery of exogenous lipids with spontaneous negative curvature equivalent to or greater than cholesterol recovered the ability of vesicles to fuse. 9, 10 Thus, in the native fusion mechanism cholesterol provides negative curvature to facilitate lipid bilayer merger,p resumably by enabling efficient formation of the stalk intermediate within the biological energy constraints.
Cholesterol not only provides a critical negative curvature to the membrane, but it also regulates the efficient interactions of other fusion components via cholesterol-and sphingomyelin-enriched domains. 9, 12 The preferential interaction between cholesterol and sphingomyelin in the membrane leads to the formation of ordered domains within the more fluid lipid matrix and specific proteins tend to partition into these regions; these properties are thought to form highly organized sites specialized to carry out specific cellular functions. [40] [41] [42] [43] In CV fusion, mβcd and cholesterol oxidase, which are known to disrupt microdomains, 24, [44] [45] [46] inhibited the kinetics, Ca 2+ -sensitivity and extent of fusion whereas filipin, each molecule of which binds together several cholesterol molecules in the membrane without disrupting domains (to some extent evens tabilizing them), 24, 45 showed a selective inhibition of the extent of fusion (with some effect on kinetics at higher doses) without affecting Ca 2+ -sensitivity.A sm entioned above, other negative curvature lipids can substitute for cholesterol in rescuing the ability of vesicles to fuse, but these (e.g. diacylglycerol, phosphatidylethanolamine, or α-tocopherol) do not support the formation of microdomains and thus do not recovert he kinetics or Ca 2+ -sensitivity of fusion.
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Furthermore, sphingomyelinase treatments, as an alternate approach to disrupt microdomains, resulted in a selective inhibition of the Ca 2+ -sensitivity of fusion. 12 This suggests that sphingomyelin participates in the organization of critical components to promote fusion efficiency (particularly some involved in Ca 2+ sensing and/or triggering) but, unlikec holesterol, does not have a direct role in the fusion mechanism. Thus, cholesterol and sphingomyelin provide organization of the critical proteins (and possibly other lipids) at or near the fusion site to ensure tight regulation of the fusion process. These critical components, lipids and proteins together,c an be collectively thought of as a fusion complexormachine.
Using thiol-reactivity to probe protein function
Thiol-reactive reagents have been used to study the roles of proteins in membrane fusion in a variety of model systems. The most commonly used reagent, Nethylmaleimide (NEM), has been shown to inhibit intracellular membrane trafficking in the endoplasmic reticulum 47 and Golgi, 48 and regulated secretion in chromaffin cells 49 and synaptosomes. 50 Early work in the urchin model system showed that NEM, among several other thiol-reactive reagents, inhibited the actual fusion step between the vesicle and plasma membrane. 21, 51, 52 Subsequent work reported that CV-CV homotypic fusion wasalso inhibited by comparable doses of NEM, consistent with a common underlying fusion mechanism.
14,15,18 CV have also been shown to undergo fusion with membranes in which the proteins have been rendered inactive byt hiolreactive reagents or proteases 18, 52 and with pure lipidic bilayers, 17, 18 indicating that the proteins essential to Ca 2+ sensing and triggering of membrane fusion are only required in one membrane.
As eries of studies investigating the mathematical relationship between the [Ca 2+ ] free and the probability of activating fusion complexesh av e led to several important insights into the fusion mechanism. [4] [5] [6] 8 Using NEM inactivation, it was estimated that each vesicle contains an av erage of 7-9 fusion complexes. 8, 15 These fusion machines are randomly distributed across the entire vesicle population and only the activation of one complexi s necessary to enable a vesicle to fuse. As individual fusion machines become inactivated the first parameter to be affected is the kinetics of fusion, making this the most sensitive measure to detect changes in the fusion machinery; however, a vesicle only becomes fusion incompetent when all of its resident fusion complexesa re inactivated. Another important observation is the characteristic sigmodial Ca 2+ activity curvefor CV-PM 8 and CV-CV fusion, 15 as well as for exocytosis in various other model systems.
1,2 These submaximal responses to low concentrations of Ca 2+ reflect a heterogeneous distribution of Ca 2+ -sensitivities among the individual fusion complexes. 4 The modulation in Ca 2+ -sensitivity may also reflect a decrease in the number of active fusion machines, butr ecent studies suggest a much more dynamic view. For example, the studies of cholesterol and sphingomyelin show ad istinct separation of the extent of fusion from the Ca 2+ -sensitivity or kinetics of fusion. This dissociation of the ability to fuse from the efficiencyo ft he fusion process is also observed when other divalent cations, such as Sr 2+ and Ba 2+ ,a re used to trigger fusion. 15, 16 These Ca 2+ mimetics retain the ability to trigger fusion but are much less efficient than Ca 2+ ,r equiring concentrations in the low millimolar range vs lowm icromolar doses for Ca 2+ .T his suggests that the fundamental fusion machine (i.e. containing only those components minimally essential for triggered fusion) has an inherently lowC a 2+ -sensitivity, with layers of modulatory components that work together (before, during and after membrane merger) to regulate the efficiencyo ft he native fusion mechanism (e.g. fusion pore formation, opening, and expansion). 11, 15, 53 This would not only allowf or different cell types to be fine-tuned for specific functions/stimuli, but would also allowf or greater plasticity within individual cells to ensure theyh av e the ability to adapt to a variety of physiological challenges.
To further expand on these observations and focus on the use of thiol-reactive reagents as unbiased tools for the analysis of mechanism, we have undertaken a comprehensive comparison of several different (but in some cases, related) compounds. Fusion of control CV showed a characteristic sigmodial Ca 2+ -activity curvewith an average EC 50 of 25.9 ± 1.2 µM[ Ca 2+ ] free ,a nd initial rate of 65.3 ± 2.8%/s, in response to 122.7 ± 7.7 µM[Ca 2+ ] free ,which was invariant overt he treatment times used. As with previous studies, we find a similar dose-dependent inhibition of fusion with NEM ( Figure 1A) . 16 With 20 min incubation times, treatment with doses of 100-750 µMN EM had no effect on fusion, while 1 mM NEM begins to inhibit the kinetics of fusion (∆ −28.7 ± 7.4%/s; p =0 .008), with a small, but statistically insignificant, rightward shift in Ca 2+ -sensitivity (∆ 8. Figure  1A) . 16 At short incubation times, treatment with 100 µM-1 mM had no effect, and 2 mM maleimide started to inhibit kinetics (∆ −26.5 ± 6.6%/s; p <0 .003). When incubations times were lengthened to 1 h, treatment with 2.5 mM maleimide started to inhibit fusion kinetics (∆ −64.0 ± 8.5%/s; p <0 .001) and Ca 2+ -sensitivity (∆ 22. .001) and extent of fusion (to 39.6 ± 11.8%; p <0.001). 10 mM maleimide was required to inhibit fusion to the same extent as seen with 5 mM NEM treatments (to 16.5 ± 9.8%; p <0 .001). This pattern of inhibition, first a decline in kinetics, then a rightward shift in Ca 2+ -sensitivity, and finally a loss of fusion competence, is consistent with previous modeling studies describing progressive inactivation of fusion complexes. 8 Iodoacetamide (IA) was found to have a biphasic effect on exocytotic fusion ( Figure 1B) . 16 In contrast to initial studies by Haggerty & Jackson that showed no effect of 5 mM IA on the ability of vesicles to fuse with the plasma membrane, 51 treatment of CV-PM complexeso r isolated CV with higher doses (≥ 10 mM) actually enhanced the efficiencyo ff usion. 16 In CV-CV fusion, treatment with 60 mM IA for 20 To further explore this unexpected discrepancy between the effects of maleimides and iodoacetamides on fusion, different derivativesofIAwere tested. Surprisingly, when IA was tagged with fluorescein it behaved comparably to NEM (Figure 1) . 16 At short incubation times, treatment with 1 mM iodoacetamidofluorescein (IAF) 50 50 ] free ; p < 0.001) and extent of fusion (to 45.1 ± 7.0%; p <0.001); this reagent could not be tested at 5 mM due to solubility limitations. Interestingly,I AF and NEM have somewhat similar structures compared to IA; both IAF and NEM contain hydrophobic carbon rings whereas IA is a highly polar,h ydrophilic molecule. Lucifer yellowt agged IA (LYIA) was also found to enhance fusion, but notably,a t much lower doses than IA alone ( Figure 1B) . 24 Treatment with 500 µM-1 mM LYIA for 20 min resulted in a leftward shift in Ca 2+ -sensitivity comparable to that seen with 10-100 mM IA, with a dose of 750 µML YIA resulting in the maximal potentiation of Ca 2+ -sensitivity (∆ 15.6 ± 5.4 µM[ Ca 2+ ] free ; p =0 .006) and fusion kinetics (∆ +33.8 ± 8.0%/s; p =0.002). Despite being negatively charged, LYIA also has carbon ring structures likeI AF and maleimides; presumably this is whyi tr etains the ability to potentiate fusion at lower concentrations. Thus, hydrophobicity seems to be associated with the ability to inhibit fusion and hydrophilicity with the ability to potentiate fusion.
h treatments with various concentrations of maleimide (MAL; n = 3-4) and N-ethylmaleimide (NEM; n = 3-5). Dashed vertical lines indicate the EC

-activity curves for 20 min and 1 h treatments with various concentrations of iodoacetamide (IA; n = 5-9), Lucifer yellow iodoacetamide (LYIA; n = 6) and iodoacetamidofluorescein (IAF; n = 3-4). Dashed vertical lines indicate the EC
Other reagents of interest were the common commercial / environmental compounds acrylamide and thimerosal, as both have been reported to have potential neurotoxic effects. [54] [55] [56] Acrylamide can be produced from a reaction between asparagine and the carbonyl groups of sugars when food is heated, 57 and thimerosal (ethylmercurythiosalicylate) has been commonly used as a preservative inv accines and various other products. 56, 58 In our experiments, treatment of CV with up to 300 mM acrylamide for 1 h showed no effect on fusion parameters (data not shown). This would suggest that inhibition of the fundamental Ca 2+ -triggered fusion mechanism is not the primary underlying cause of acrylamide-induced nerve terminal degeneration, but that disruptions at other stages of membrane trafficking / exocytosis may lead to the perturbations in neurotransmitter release previously observed. 54, 55 In contrast, thimerosal ( Figure 2A ) was an extremely potent inhibitor of fusion evenatshort incubation times. Treatment with 500 µMt himerosal for 20 min resulted in an all but complete inhibition of initial fusion kinetics (∆ −62.8 ± 8.9%/s; p <0.001) and a large rightward shift in Ca 2+ -sensitivity (∆ 41.5 ± 12.0 µM[ Ca 2+ ] free ; p = 0.001), without affecting the ability of vesicles to fuse. At 1 hi ncubation times, kinetics were inhibited at doses as low as 50 µMt himerosal (∆ −25.5 ± 6.5%/s; p =0 .001). Predictably,t reatment with 500 µMt himerosal for 1 h resulted in an almost complete inhibition of kinetics (∆ −74.6 ± 7.2%/s; p <0.001), a pronounced rightward shift in Ca 2+ -sensitivity (∆ 126.4 ± 20.2 µM[ Ca 2+ ] free ; p <0 .001) and a marked inhibition of the extent of fusion (to 42.2 ± 13.4%; p <0.001); treatment with 1 mM thimerosal for 1 h essentially abolished the ability of the vesicles to fuse (7.8 ± 2.7%; p <0 .001). These data showt hat thimerosal exposure can effect the fundamental mechanism of Ca 2+ -triggered membrane fusion, in addition to other potential side effects such as oxidative stress 59, 60 and perturbations in calcium signaling. 58, 61 It should howeverbe noted that the relationship between specific experimental dosages and the accumulation of thimerosal in biological tissues from environmental exposure has not been thoroughly explored. Nonetheless, these data minimally indicate a strong potential role for thimerosal as a research tool for identifying critical components of the fusion mechanism, particularly in relation to Ca 2+ sensing/triggering. Another distinct group of thiol-reactive compounds are the vicinal thiol reagents, such as phenylarsine oxide (PAO)a nd diamide (DA). The term vicinal refers to two adjacent functional groups, but with proteins it has been generally accepted to include cysteine residues within close enough proximity in the tertiary structure to allowf or the formation of disulfide bridges. 62 POA, which has a carbon ring structure, was a potent inhibitor of membrane fusion whereas as the non-cyclic DAw as substantially less effective ( Figure 2B ). At 20 min incubation times, treatment with 100 µMP AO first started to inhibit kinetics (∆ −45.2 ± 17.2%/s; p <0.001), and 500 µMP AO inhibited kinetics (∆ −59.6 ± 10.3%/s; p <0 .001), Ca 2+ -sensitivity (∆ 25.2 ± 9.3 µM[Ca 2+ ] free ; p =0.002) and extent of fusion (to 63.1 ± 15.3%; p =0 .05). In contrast, treatment with 1 mM DAy ielded a slight but significant decrease only in initial fusion kinetics (∆ −16.0 ± 6.5%/s; p =0 .042). Following 1 h incubations, kinetics were inhibited at a dose of 100 µMP AO (∆ −42.6 ± 11.8%/s; p =0 .001) while treatment with 500 µMP AO markedly inhibited the ability of vesicles to fuse (final extent, 19.8 ± 10.4%; p <0 .001). For1hi ncubations with DA, initial fusion kinetics were first inhibited at a dose of 1 mM DA(∆ −22.4 ± 7.4%/s; p = 0.042). Treatment with 5 mM DAf or 1 h resulted in an almost complete knockdown of initial fusion kinetics (∆ −47.5 ± 6.3%/s; p <0 .001), a substantial rightward shift in Ca 2+ -sensitivity (∆ 46.6 ± 11.6 µM[ Ca 2+ ] free ; p <0 .001) and a potent inhibition of the extent of fusion (to 56.7 ± 9.6%; p =0 .002). Doses of 10 mM DAw ere required to knockdown fusion (to 8.5 ± 3.9%; p <0 .001) to levels comparable to those seen following treatments with 500 µMP AO.C omparable differences in the relative effective concentrations of POAand DAhav e been reported for other membrane proteins. 63 These systematic comparisons of a range of different thiol reagents indicate that hydrophobic ring structures, which have a tendencyt oi ntercalate into membranes, 64 are defining structural characteristics of those reagents that are most effective ati nhibiting fusion; in contrast, more polar or charged reagents, which tend to be membrane impermeable, 65 have the ability to potentiate fusion. It remains unclear whether or not these more hydrophobic reagents have the ability to react with 'potentiation' sites; under the conditions tested here, theys eem to react so potently with the 'inhibition' sites that a potentiation effect may be masked. These differential effects suggest that two or more distinct thiol sites are involved in the Ca 2+ -triggered membrane fusion mechanism. First, there is at least one site that is easily accessible to hydrophobic reagents, presumably near the membrane or buried within a hydrophobic region of a secretory vesicle membrane protein or protein complex, that is critical for the ability to fuse. The potentencyo fv icinal thiol reagents, especially PA O,s uggests that this particular component of the fusion mechanism may involvet he interaction between two closely associated cysteine residues. Interactions between vicinal thiols can induce dramatic changes in protein conformation and are thought to act as on/offs witches for protein function. 66, 67 Secondly,t here is at least one other distinct thiol site(s) on a secretory vesicle membrane protein or protein complext hat can regulate the efficiency of fusion. The polar / charged reagents, IA and LYIA, readily react with a site that enhances the Ca 2+ -sensitivity of fusion, perhaps by directly modulating the affinity of Ca 2+ binding or Ca 2+ -dependent protein interaction with the fusion machine as thiol modification is known to alter the Ca 2+ -affinity of other Ca 2+ binding proteins. 68, 69 Overall, the simplest interpretation of these data is that both of the critical thiol sites are located on the same protein -the Ca 2+ -sensor -in which a hydrophilic site alters its Ca 2+ -affinity and a hydrophobic site inhibits the conformational changes and/or interactions required to trigger fusion. Yet, the emerging viewi st hat the fusion machinery consists of several proteins and lipid species working in concert to ensure fast, localized secretion. There are likely critical components that underlie the highly conserved lipid merger step, as well as several regulatory proteins that can optimize the Ca 2+ -triggering steps, allowing for the dynamic regulation of secretion in terms of specific cell functions.
Similar to the approaches used in studies of lipids 9, 10, 12 and Ca 2+ mimetics, 15, 16 different thiol-reactive reagents can be used to separate the roles of molecular components in fusion efficiency vs fusion competence. The most prominent example here being the novelf usionpromoting effect of iodoacetamides; nonetheless, differences in the potencyo ft he reagents to inhibit Ca 2+ -sensitivity were also observed. At short incubation times, IAF ( Figure 1B ; 20 min) resulted in a substantial inhibition of kinetics (∆ −46.3 ± 21.6%/s) and extent (to 58.2 ± 9.9%) without a significant shift in the Ca 2+ -sensitivity (∆ 8.1 ± 7.9 µM[ Ca 2+ ] free ). In contrast, thimerosal (Figure 2A ; 20 min) produces a large, selective rightward shift in Ca 2+ -sensitivity (∆ 41.5 ± 12.0 µM [Ca 2+ ] free )and knockdown of initial fusion kinetics (∆ −62.8 ± 8.9%/s) without affecting fusion competency( 100.4 ± 6.2%). In general, the ability of reagents to inhibit Ca 2+ -sensitivity was thimerosal > maleimides > iodoacetamides.
One interpretation of the work with Ca 2+ mimetics is that these cations are capable of interacting with the Ca 2+ -binding site necessary to trigger fusion but not accessory binding sites involved in efficiency. 15 Thiol reagents may alter the function of these 'secondary' Ca 2+ -sensors to either increase or decrease the Ca 2+ -sensitivity of the fusion complex, and thereby regulate fusion efficiency. Modifying thiol sites may thus directly affect Ca 2+ -affinity or block interactions with regulatory proteins, yet it becomes difficult to pinpoint exact roles in the fusion mechanism until we knowt he identity of the proteins involved and their interacting partners.
Identification of critical proteins
Although thiol-reactivity has been used to probe protein function in Ca 2+ -triggered membrane fusion for more than twod ecades, the identities of most of the proteins these reagents react with remain unknown. Early experiments with NEM led to the isolation of a NEM sensitive factor (NSF) protein, 70 soluble NSF attachment protein (α-SNAP), 71 and SNARE (SNAP receptor) proteins. 72 Current working hypotheses concerning the mechanisms involved in membrane trafficking and exocytosis are centered around the interactions between these proteins 73 and their various binding partners, including the Ca 2+ -binding protein synaptotagmin. 74 The interactions between the cytosolic domains of SNARE proteins have been proposed to regulate vesicle docking, 72 as well as drive lipid bilayer merger. 75 However, fusionready CV retain the ability to undergo triggered fusion even after the quantitative removalo fS NARE cytosolic domains. 11 Furthermore, the blockade of SNARE-SNARE or SNARE-synaptotagmin interactions with recombinant proteins does not inhibit Ca 2+ -triggered fusion. 13 These results have been confirmed in studies of reconstituted SNARE liposome systems. 76, 77 These studies indicate that SNARE cytosolic domain interactions do not play a direct role in the fusion mechanism (e.g. membrane merger steps); however, this does not preclude them from participating in the physiological modulation or promotion of fusion efficiency. 11, 15, 53 Thiol-reactive reagents provide an unbiased tool to identify both known and unknown proteins that are involved in the Ca 2+ -triggering (and other) steps of membrane fusion. The differential effects of thiol-reactive reagents can be used to target proteins with specific roles in the fusion mechanism, and the fluorescent analogues can be used to label candidate proteins. Thorough characterization of the novelp otentiation effect of IA indicates that it enhances the Ca 2+ -sensing mechanism. 16 The fluorescently tagged LYIA produced a leftward shift in Ca 2+ -sensitivity comparable to that seen after treatment with IA ( Figure  1B) ; as there was no effect of the LYfl uorophore itself, these results suggest that LYIA reacts with the same critical thiol site(s) as IA. 24 Thus, treatment with LYIA can be used to potentiate fusion while simultaneously labeling critical proteins, perhaps evenaC a 2+ sensor.A fter functional analyses, the membranes from treated CV were isolated and resolved by two-dimensional electrophoresis (2DE). 25 Due to the fact that LYIA is charged, labeling can be assessed by shifts in the isoelectric points of proteins ( Figure 3B ) relative tot he control CV proteome following 2DE ( Figure  3A) as well as by direct detection of the LYfl uorescence ( Figure 3C) . A large portion of CV membrane proteins were found to be labeled, yet this is not entirely unexpected. Even at the lowd oses used to achieve potentiation, these thiol reagents are not specific, such that the sites involved in Ca 2+ -sensing are not necessarily the most abundant or reactive ofthe available sulfhydryl groups.
Recent work on cholesterol and sphingomyelin has clearly delineated a role for these molecules in the regulation of fusion efficiency. 9, 12 Due to the ability of cholesterol and sphingomyelin to form ordered membrane domains in which specific groups of proteins reside, [40] [41] [42] [43] it is likely that these cholesterol-and sphingomyelin-enriched regions organize proteins (and possibly other lipids) critical to fusion. Several proteins linked to exocytosis have been found within these domains, so it is likely that proteins involved in the Ca 2+ -sensing steps of triggered fusion are also closely associated with cholesterol. The exact nature of microdomains / cholesterol-enriched membrane regions remains controversial: do the biochemical isolates reflect biological states or are theya rtifacts of the isolation protocol? 40, [78] [79] [80] Recent experiments visualizing microdomains in living cells showt hat cholesterol and sphingomyelin do indeed provide organization in intact cell membranes and that these domains can be extremely dynamic and heterogeneous. [81] [82] [83] [84] Nonetheless, the isolation and characterization of cholesterol-enriched membrane fractions can be used as a prefractionation method to study as pecific subset of proteins that tend to associate with cholesterol in the membrane; this not only reduces the complexity of the proteome but should also enhance our ability to detect lowa bundance proteins (protein enrichment). Tom inimize possible artifacts, CV membranes fragments were fractionated by sucrose density centrifugation in a Tris buffer without detergents to isolate the cholesterol-enriched regions before resolving proteins by 2DE. 24 In comparison to the total CV membrane proteome, the cholesterol-enriched fraction has a markedly reduced number of protein spots, indicating the selective enrichment of certain proteins. Consistent with the functional effects on fusion, treatment with cholesterol binding antibiotics maintained domain integrity whereas mβcd treatment resulted in complete loss of the cholesterolenriched fraction. 24 Thus, of particular interest here are proteins that are both contained in cholesterol enriched regions and that become labeled with LYIA ( Figure 3D ). Identification of these proteins will lead to possible candidates that can be further tested for roles in the Ca 2+ -sensing mechanism of triggered membrane fusion.
Summary
In recent years, several key advances have been made in understanding the molecular mechanisms underlying Ca 2+ -triggered membrane fusion. The field has started to appreciate that both proteins and lipids are critical components of an integrated, conserved fusion machine. Analyses of the roles of lipids in the fusion process has been greatly facilitated by the stalk-pore model, providing a more detailed understanding of the energetics involved in lipid bilayer merger.This has led to clearly defined roles for cholesterol and lipids of comparable negative curvature in the native,C a 2+ -triggered membrane fusion mechanism.
Cholesterol not only participates directly in the formation of fusion intermediates, but also, along with sphingomyelin, organizes other components of the fusion machinery. Although there is strong evidence that proteins are required for Ca 2+ -sensing and the triggering of fusion, there has been limited progress in definitively establishing their identities. Our recent work has focused on using thiol-reactivity as an unbiased tool for investigating the possible roles of proteins in membrane fusion. By coupling sensitive functional and molecular analyses of isolated secretory vesicles, the aim is to identify the proteins targeted by these thiol reagents, thereby furthering our understanding of this fundamental cellular process.
